CIK 0001321834 · Non-accelerated filer<br>Smaller reporting company
Q/C TECHNOLOGIES, INC.
Sign in to watch- Ticker
- QCLS
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 856-848-8698
- Business address
- 1185 AVENUE OF THE AMERICAS, SUITE 249, NEW YORK, NY, 10036
- Former names
- Q/C TECHNOLOGIES, INC., TNF Pharmaceuticals, Inc., MyMD Pharmaceuticals, Inc., Akers Biosciences, Inc., Akers Biosciences Inc
- D Other Notice of Sales of Unregistered Securities
- 10-K Report Annual Report
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Material agreement · Unregistered share sale
- NT 10-K Other NT 10-K
- 5 Insider Annual Insider Trading Report
- 8-K Event Other events
- 424B5 Offering Prospectus
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 8-K Event Shareholder vote results
- EFFECT Other Notice of Effectiveness
- FWP Offering Free Writing Prospectus
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3/A Offering Registration Statement
- 10-Q Report Quarterly Report
- DEF 14A Proxy Proxy Statement
- UPLOAD Other SEC-generated Letter
Page 26 of 31 · 604 filings